When CD8 T cells were depleted from melanoma, TILs and the remaining T cells (median 89% CD4 T cell composition assessed by flow cytometry) were assayed for tumor reactivity; about 20% showed tumor reactivity as assessed by IFNγ production (61). This evidence concerns the gene CD4 and melanoma.